跳至主要内容
临床试验/NCT03680040
NCT03680040终止不适用

Prospective Non-randomized Single Arm Multi-center Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65 (RESILIENCE Trial)

Edwards Lifesciences10 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2018年11月5日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
110
试验地点
10
主要终点
Time to bioprosthetic valve failure due to valve deterioration

研究概览

简要总结

The objective of this observational trial is to determine time to valve failure due to valve deterioration requiring re-intervention and collect/investigate early potential predictors of valve durability (e.g., calcification and hemodynamic deterioration) in RESILIA tissue valves.

详细描述

Multicenter, prospective, non-randomized, single-arm, observational trial. Subjects will be evaluated at 5, 7, 9, and 11 years post-implant. Up to two hundred fifty (250) total subjects at up to fifteen (15) investigational sites will be enrolled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Subject currently has an Edwards pericardial aortic bioprosthesis with RESILIA tissue
  • Provides voluntary written informed consent prior to the first trial related procedure
  • Subject agrees to attend follow-up assessments as specified in the protocol

排除标准

  • Age 65 years or older at time of aortic valve replacement
  • The Subject is pregnant or planning to become pregnant at the time of screening
  • Re-intervention required on the bioprosthetic aortic valve prior to screening
  • Active endocarditis or history of endocarditis on bioprosthetic aortic valve
  • Estimated life expectancy <24 months
  • Subjects with history of or current renal failure requiring dialysis
  • Altered mineral metabolism (hyperparathyroidism, parathyroid tumors)
  • Has prior organ transplant or is currently an organ transplant candidate

结局指标

主要结局

Time to bioprosthetic valve failure due to valve deterioration

时间窗: 11 years post-implant

Time to bioprosthetic valve failure due to valve deterioration is defined as subject requiring valve re-intervention (redo surgery, valve-in-valve) or confirmed study valve-related death.

次要结局

  • Collection of early possible predictors of valve failure including leaflet calcification and morphological/hemodynamic valve deterioration(5, 7, 9, and 11 years post-implant)

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验